Tirzepatide, a innovative medication, is creating considerable buzz within the healthcare community. It functions differently from traditional diabetes therapies , targeting two receptors involved in sugar regulation and appetite . Initial trials have demonstrated impressive efficacy in lowering blood glucose in individuals with adult-onset diabete